3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Sarcoma
19
Ovarian Neoplasms
7
Leiomyosarcoma
6
Liposarcoma
4
Liposarcoma, Myxoid
3
Sarcoma, Ewing
2
Osteosarcoma
2
Solitary Fibrous Tumors
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyosarcoma Uterus
1
Ichthyosis, X-Linked
1
Histiocytoma, Malignant Fibrous
1
Hemangioendothelioma
1
Fanconi Anemia, Complementation Group D1
1
Chondrosarcoma
1
Carcinosarcoma
1
Cancers With DNA Repair-Deficiency
1
Bone Neoplasms
1
Interventions
olaparib
3
Carboplatin
2
pembrolizumab
1
Trabectedin
1
Surveys and Questionnaires
1
Secretin
1
Paclitaxel
1
Genotype
1
Genetic Counseling
1
Demography
1
Data Collection
1
Cognitive Behavioral Therapy
1
Biopsy, Fine-Needle
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fanconi Anemia, Complementation Group D1
×
Trabectedin
×
Clear all
NCT01772979
2013-01-21
MITO15
Catholic University of the Sacred Heart
Phase 2
Unknown
100 enrolled